Olive Sensing

Executive Summary

Olive Sensing is a San Francisco-based digital diagnostics company founded in 2018 that has developed the world's first 100% passive, non-invasive, real-time urinalysis sensor designed to mount onto any toilet. The sensor enables continuous health monitoring by analyzing urine biomarkers without any user intervention, facilitating early disease detection and chronic disease management from the comfort of home. This innovative approach addresses a critical gap in preventive healthcare, offering a seamless way to track kidney function, hydration, metabolic health, and potential infections daily. By leveraging IoT and data analytics, Olive Sensing aims to transform routine health monitoring into a proactive, data-driven practice, reducing the burden on healthcare systems and empowering individuals with actionable insights. The company operates in the rapidly growing home diagnostics market, valued at over $50 billion and expanding as consumers seek convenient, non-invasive health tracking tools. Olive Sensing's sensor has the potential to become a standard fixture in smart homes and connected healthcare ecosystems, particularly for managing chronic conditions like diabetes, hypertension, and kidney disease. Initial validation through pilot studies and partnerships with healthcare providers could accelerate adoption. While still early-stage, Olive Sensing's technology represents a paradigm shift in continuous health monitoring, with significant implications for population health management. The company's success hinges on navigating regulatory pathways, securing strategic partnerships, and demonstrating clinical utility in real-world settings.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Urinalysis Sensor40% success
• Q2 2026Strategic Partnership with Major Hospital System or Diagnostic Lab50% success
• Q1 2026Series A or Seed Extension Funding Round60% success